JOURNAL HOME CME HOME THIS MONTH PAST ISSUES ETOC COLLECTIONS
AUTHORS REVIEWERS EDITORIAL BOARD FEEDBACK RSS HELP
A&A International Anesthesia Research Society
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a colleague
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (3)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Larsson, A.
Right arrow Articles by Eriksson, M. B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Larsson, A.
Right arrow Articles by Eriksson, M. B.
Related Collections
Right arrow Critical Care
Right arrow Resuscitation

Anesth Analg 2005;101:1465-1469
© 2005 International Anesthesia Research Society
doi: 10.1213/01.ANE.0000180193.29655.6A


CRITICAL CARE AND TRAUMA

Slight Increase of Serum S-100B During Porcine Endotoxemic Shock May Indicate Blood-Brain Barrier Damage

Anders Larsson, MD, PhD*, Miklós Lipcsey, MD{dagger}, Jan Sjölin, MD, PhD*, Lars-Olof Hansson, MD, PhD*, and Mats B. Eriksson, MD, PhD{dagger}

Departments of *Medical Sciences and {dagger}Surgical Sciences, Uppsala University Hospital, Sweden

Address correspondence and reprint requests to Anders Larsson, MD, PhD, Department of Medical Sciences, University Hospital S-751 85 Uppsala, Sweden. Address e-mail to anders.larsson{at}akademiska.se.

Septic shock is a condition that affects many organs, but little is known about the effects on the central nervous system. S-100B, an acidic low molecular weight protein, has attracted considerable interest as a marker for brain damage and disintegration of the blood-brain barrier. It is released into the cerebrospinal fluid and blood from brain tissue after brain damage. We studied S-100B in a porcine model of endotoxemic shock that resembles human Gram-negative septic shock. Ten piglets received IV endotoxin, and plasma samples were collected before the endotoxin infusion and each hour (1–6 h) during the endotoxin infusion. S-100B was measured by sandwich enzyme-linked immunosorbent assay. Low levels of plasma S-100B were detected, but there was a significant increase in S-100B during Hours 1–5 in comparison with the 0 values. We determined that endotoxemia causes a very small but significant increase in the levels of the widely used brain damage marker serum S-100B. However, it cannot be excluded that the increase in S-100B could be caused by release from organs other than the brain.




This article has been cited by other articles:


Home page
Anesth. Analg.Home page
N. Stocchetti
Brain and Sepsis: Functional Impairment, Structural Damage, and Markers
Anesth. Analg., November 1, 2005; 101(5): 1463 - 1464.
[Full Text] [PDF]




Lippincott, Williams & Wilkins Anesthesia & Analgesia® is published for the International Anesthesia Research Society® by Lippincott Williams & Wilkins with the assistance of Stanford University Libraries' HighWire Press®. Copyright 2006 by the International Anesthesia Research Society. Online ISSN: 1526-7598   Print ISSN: 0003-2999 HighWire Press
Copyright © 2005 by the International Anesthesia Research Society.